What is the objective of the mass balance study? A retrospective analysis of data in animal and human excretion studies employing radiolabeled drugs (Q33278984)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	What is the objective of the mass balance study? A retrospective analysis of data in animal and human excretion studies employing radiolabeled drugs	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

Europe PubMed Central

What is the objective of the mass balance study? A retrospective analysis of data in animal and human excretion studies employing radiolabeled drugs (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

author name string

Sarah J Roffey

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

R Scott Obach

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Jenny I Gedge

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Dennis A Smith

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

0 references

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Drug Metabolism Reviews

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

39

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

17-43

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Metabolic fate of zetidoline, a new neuroleptic agent, in man.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Disposition and biotransformation of the acetylenic retinoid tazarotene in humans

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Metabolism, excretion and pharmacokinetics of a single dose of [14C]-raltitrexed in cancer patients

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Mass balance studies, with a focus on anticancer drugs.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Trabectedin (Yondelis, formerly ET-743), a mass balance study in patients with advanced cancer.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Pharmacokinetic and mass balance study of unlabelled and (14)C-labelled emedastine difumarate in healthy volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Metabolism and excretion of capravirine, a new non-nucleoside reverse transcriptase inhibitor, alone and in combination with ritonavir in healthy volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Evaluation of the absorption, excretion and metabolism of [14C] etoperidone in man.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Metabolism and excretion of the antiepileptic/antimigraine drug, Topiramate in animals and humans

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Metabolism of Cefotaxime in Animals and Humans

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Identification of urinary metabolites of penticainide in the rat, dog, baboon and man.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Comparative pharmacokinetic profile of two imidazopyridine drugs: zolpidem and alpidem

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Pharmacokinetics of [14C]FCE 22891, a penem antibiotic, following oral administration to healthy volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Pharmacokinetics of 14C-delmopinol in the healthy male volunteer.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Evaluation of accelerator mass spectrometry in a human mass balance and pharmacokinetic study-experience with 14C-labeled (R)-6-[amino(4- chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1- methyl-2(1H)-quinolinone (R115777), a far

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Metabolism and disposition of imatinib mesylate in healthy volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

The disposition and metabolism of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in human subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

The disposition and metabolic fate of 14C-meropenem in man.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Absorption of colesevelam hydrochloride in healthy volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Metabolism, pharmacokinetics, and excretion of a highly selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in human cytochrome P450 2D6 extensive and poor metabolizers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Metabolism and excretion of tolcapone, a novel inhibitor of catechol-O-methyltransferase

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Disposition of posaconazole following single-dose oral administration in healthy subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Metabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Studies on the mechanism of drug-binding to melanin

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Clinical pharmacokinetics of amiodarone

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Binding of drugs to eye melanin is not predictive of ocular toxicity

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Basic pharmacokinetics of bisoprolol, a new highly beta 1-selective adrenoceptor antagonist

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Pharmacokinetics and metabolism of rosaramicin in humans

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Chloroquine causes lysosomal dysfunction in neural retina and RPE: implications for retinopathy

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Pharmacokinetics and metabolism of lumiracoxib in healthy male subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Fate and disposition of bromocriptine in animals and man. II: Absorption, elimination and metabolism

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

On the pharmacokinetics of domperidone in animals and man III. Comparative study on the excretion and metabolism of domperidone in rats, dogs and man.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

The metabolic fate of the anti-androgenic agent, oxendolone, in man.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Disposition of radiolabeled imipenem and cilastatin in normal human volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Absorption, distribution and excretion of 14C-chloroquine after single oral administration in albino and pigmented rats: binding characteristics of chloroquine-related radioactivity to melanin in-vivo

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Metabolic disposition of 14C-bromfenac in healthy male volunteers.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

The bioavailability and disposition of 1-(beta-D-arabinofuranosyl)-5-(1-propynyl)uracil (882C87), a potent, new anti-varicella zoster virus agent

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Pharmacokinetics of [14C]-labelled Losigamone and enantiomers after oral administration to healthy subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

The metabolic profile of azimilide in man: in vivo and in vitro evaluations

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Absorption, metabolism, and excretion of etoricoxib, a potent and selective cyclooxygenase-2 inhibitor, in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Zatebradine: pharmacokinetics of a novel heart-rate-lowering agent after intravenous infusion and oral administration to healthy subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Pharmacokinetics of falipamil after intravenous administration to humans.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

The metabolism of nicardipine hydrochloride in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Metabolic disposition and pharmacokinetics of [14C]-amprenavir, a human immunodeficiency virus type 1 (HIV-1) protease inhibitor, administered as a single oral dose to healthy male subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90).

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Mass balance study of [14C]M100240, a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, in healthy male subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Disposition in male volunteers of a subanaesthetic intravenous dose of an oil in water emulsion of 14C-propofol

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Disposition of fosinopril sodium in healthy subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Dose-dependent pharmacokinetics of acetaminophen: evidence of glutathione depletion in humans.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Pharmacokinetics, metabolism and excretion of intravenous [l4C]-palonosetron in healthy human volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Absorption, distribution, metabolism and excretion of [14C]levocetirizine, the R enantiomer of cetirizine, in healthy volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Clinical pharmacokinetics of mirtazapine

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Invited review: fluphenazine augments retinal oxidative stress

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Pharmacokinetics of compound 58-112, a potential skeletal muscle relaxant, in man.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

An excretion balance and pharmacokinetic study of the novel anticancer agent E7070 in cancer patients

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

The in vivo human metabolism of tibolone

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral dose

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

The disposition of chloroquine in healthy Nigerians after single intravenous and oral doses

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

High absorption but very low bioavailability of oral resveratrol in humans

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Pharmacokinetics and metabolism of the cholecystokinin antagonist dexloxiglumide in male human subjects

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humans

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

The metabolism of [14C]N-ethoxycarbonyl-3-morpholinosydnonimine (molsidomine) in man.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Single-dose accumulation pharmacokinetics of tobramycin and netilmicin in normal volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Comparative disposition of [14C]ertapenem, a novel carbapenem antibiotic, in rat, monkey and man.

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

14C-isomazole disposition in man after oral administration

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Accelerator mass spectrometry (AMS): recent experience of its use in a clinical study and the potential future of the technique

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Disposition of a specific cyclooxygenase-2 inhibitor, valdecoxib, in human

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Metabolic profiles of minimally absorbed orlistat in obese/overweight volunteers

1 reference

https://api.crossref.org/works/10.1080%2F03602530600952172

21 January 2018

Identifiers

10.1080/03602530600952172

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33278984&oldid=1622139062"